Founder and CEO, Jade Biomedical
Dr. Claudia Qiao Lin, Founder and CEO of Jade Biomedical, studied at Fudan University and graduated from University of California, Berkeley with a doctoral degree in Cell & Molecular Biology, with a focus of cancer research. Dr. Lin has more than 20 years of working experience in R&D and pharmaceutical product development with several of the top 10 global biopharmaceutical companies. She directly participated in Quality Management from pre-clinical research to commercial technical operations of leading biologics including Avastin, Perjeta, Kavoltry, Elyea, to name a few. She held various GMP Quality Leadership positions with Genentech/Roche and Bayer AG Biotech including QA, QC, Global Techology Transfer, Annual Product Quality Review and site Quality head. Dr. Lin is a world-class technical and business leader with proven track record in the world’s Biopharmaceutical Industry.